[Updated] Healthtech firm Biofourmis to earn unicorn status with General Atlantic funding

[Updated] Healthtech firm Biofourmis to earn unicorn status with General Atlantic funding

Photo by National Cancer Institute on Unsplash

Digital therapeutics firm Biofourmis, which was founded in Singapore, is set to bag new funding from growth equity firm General Atlantic in a deal that will value it at over $1 billion, according to two sources familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter